Search for: "Abbott Laboratories, Inc." Results 321 - 340 of 450
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2012, 11:09 am by Seyfarth Shaw LLP
Co-authored by Richard Alfred and Jessica Schauer The Seventh Circuit ruled yesterday that pharmaceutical sales representatives (“PSRs”) for Eli Lilly & Co. and Abbott Laboratories Inc. are exempt from overtime under the Fair Labor Standards Act (“FLSA”) under the Administrative Exemption. [read post]
18 May 2009, 5:00 am
Austin sits on the boards of Abbott Laboratories, Teledyne Technologies Incorporated, and LM Ericsson Telephone Company. [read post]
2 Apr 2009, 5:06 am
Abbott Laboratories, 2008 WL 4401367, at *5 (E.D.Tenn. [read post]
5 Dec 2014, 9:00 am
  The Seventh Circuit weighed in on the defense side under similar circumstances in In re Abbott Laboratories, Inc., 698 F.3d 568 (7th Cir. 2012), which we commented on here. [read post]
15 Sep 2011, 5:00 am by Bexis
Abbott Laboratories, 447 F.3d 861, 867 [read post]
17 Sep 2010, 9:15 am by Stefanie Levine
Patent No. 6,703,403 owned by Abbott Laboratories and entitled METHOD FOR IMPROVING PHARMACOKINETICS. [read post]
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
19 Jan 2024, 4:00 am by Alan Macek
The approach in [Abbott Laboratories v Canada (Minister of Health), 2009 FC 648] suggests that where an inventor can trace the origin of the divisional back to the forced divisional application it will be immune from double patenting attacks. [read post]
9 Nov 2015, 4:00 am by Alan Macek
If the Canadian patent office requires that a divisional application be filed pursuant to Section 36(2.1) of the Patent Act, a court has held that it would “be unfair and inequitable” (see Abbott Laboratories v. [read post]
6 Dec 2010, 2:36 am by Kelly
Johnson & Johnson (Kluwer) EWHC (Pat) finds no infringement of coronary stent patents: Abbott Laboratories Limited v. [read post]
15 Jan 2008, 3:06 am
filed 03/22/07 1:07-cv-01721 Abbott Laboratories et al v. [read post]
28 Oct 2011, 7:06 am by John Hopkins
Abbott LaboratoriesAbbott is into using lawsuits to further its own interests. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
5 Jul 2009, 2:23 pm
After a reported five hours of deliberation, the jury in Centocor Inc v Abbott Laboratories awarded the Johnson & Johnson unit $1.67 billion for Abbott's willful infringement. [read post]